Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 102 results for "zydus research centre"

Zydus launches Adalimuma

Zydus Cadila announced the launch of its biosimilar Adalimumab, following an approval from the Drug Controller General (India). According to a press release, the biosimilar was developed by researchers at the Zydus Research Centre. To be marketed ... Financial Express, 1 month ago

CROs in a Fix Post GVK Episode

HYDERABAD: With city-based GVK Biosciences Pvt Ltd coming under the European regulator's lens, contract research organisations (CROs) conducting bio-equivalence (BE)/bio-availability (BA) studies on behalf of pharmaceutical companies have come under ...
 New Indian Express1 month ago

A Zydus lança o primeiro biossimilar do Adalimumab do mundo

NOVA DELHI , 9 de dezembro de 2014 /NEWS.GNOM.ES/ — Após uma espera de mais de uma década, a terapia revolucionária, que proporcionou uma nova chance para milhões de pacientes no mundo sofrendo de artrite reumatoide e outras doenças ...
 Gnom.es1 month ago

Inflammatory Bowel Diseases (IBD): World Drug Industry and Market 2015-2025

/PRNewswire/ -- Report Details Treating Crohn's disease and ulcerative colitis - how to find R&D trends, opportunities and revenue prospects What's the future of medicines for inflammatory bowel disease (IBD)? Those intestinal treatments ...
 Tutorial Finder3 days ago Hepatitis C Therapies: World Industry, R&D and Market Forecasts 2015-2025  ADVFN India1 month ago
Financial Express

The Gujarat Model: Is it the way forward?

Gujarat has done very well in some sectors but with its health indicators still lagging behind, will it be the blueprint for the rest of India? By Raelene Kambli Sickle Cell Anemia Control Programme Gujarat's model of development has been ...
 Financial Express1 week ago

Pharmaceutical Newsletter - December 29, 2014 to January 02, 2015

Top News Dr Reddy's Labs plans to expand into domestic market According to the report, Dr Reddy's Laboratories is planning to expand its R&D team for products into the domestic market. The company plans to launch 30 products every year and ...
 India Infoline3 weeks ago Pharmaceutical Newsletter - November 17 to 21, 2014  India Infoline2 months ago

Indian stock market and companies daily report (December 10, 2014, Wednesday)

ets are expected to open on a negative note tracking the SGX Nifty and Asian markets. US markets recovered and close flat after the initial fall due to ongoing concerns about the global economic outlook amid a sell-off in the overseas markets. ...
 Stock Markets Review1 month ago

CPhI India report forecasts new MNCs to emerge from India's pharma SMEs

India is set to take a larger share of European and USA generics markets as demand expands, with generics still representing the core strength of manufacturers. Moreover, as developing nations continue to grow their healthcare systems, the market ...
 PharmaBiz1 month ago

Dr. Datsons Labs to receive Transformational & Come Back Company of the year at Pharmaleaders

Dr. Datsons Labs to receive Transformational & Come Back Company of the year for sustained healthcare innovations Dr. Datsons Labs bounces back with transformation in healthcare excellence, voted as Transformational & Come Back Company of the year ...
 PharmiWeb1 month ago Shahnaz Husain, Pankaj Patel,Dr V Mohan,Dr Somaraju,Dilip Surana, among others to receive Pharmaleaders 2014 Awards  IndiaPRwire2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less